The bronchodilator and cardiac stimulant effects of Thll65a, salbutamol and isoproterenol.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D000336:Aerosols; D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced; D001993:Bronchodilator Agents / Q000494:pharmacology*; D002082:Butylamines / Q000494:pharmacology; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006632:Histamine; D006634:Histamine H1 Antagonists / Q000494:pharmacology; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000008:administration & dosage / Q000494:pharmacology*; D008170:Lung Compliance / Q000187:drug effects; D008297:Male; D009921:Metaproterenol / Q000494:pharmacology*; D010627:Phenethylamines / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology; D010862:Pilocarpine / Q000037:antagonists & inhibitors; D013268:Stimulation, Chemical; D013997:Time Factors; D014132:Trachea / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D000336:Aerosols; D001993:Bronchodilator Agents; D002082:Butylamines; D004983:Ethanolamines; D006634:Histamine H1 Antagonists; D010627:Phenethylamines; D010636:Phenols; D010862:Pilocarpine; D009921:Metaproterenol; D006632:Histamine; D007545:Isoproterenol